Current treatment protocols have eliminated the prognostic advantage of type 1 fusions in Ewing sarcoma: a report from the Children's Oncology Group.

van Doorninck, John A

Current treatment protocols have eliminated the prognostic advantage of type 1 fusions in Ewing sarcoma: a report from the Children's Oncology Group. [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology Apr 2010 - 1989-94 p. digital

Publication Type: Comparative Study; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural

1527-7755

10.1200/JCO.2009.24.5845 doi


Adolescent
Adult
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Biopsy
Bone Neoplasms--genetics
Chi-Square Distribution
Child
Child, Preschool
Disease-Free Survival
Female
Gene Expression Regulation, Neoplastic
Genetic Predisposition to Disease
Humans
Infant
Kaplan-Meier Estimate
Logistic Models
Male
Oncogene Proteins, Fusion--genetics
Phenotype
Prospective Studies
Proto-Oncogene Protein c-fli-1--genetics
RNA-Binding Protein EWS
Reverse Transcriptase Polymerase Chain Reaction
Risk Assessment
Risk Factors
Sarcoma, Ewing--genetics
Time Factors
Transcription Factors--genetics
Treatment Outcome
United States
Young Adult